✦ LIBER ✦

Phase II trial of gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas

✍ Scribed by Jeeyun Lee; Tae-You Kim; Myung Ah Lee; Myung Ju Ahn; Hoon-Kyo Kim; Ho Yeong Lim; Nam Su Lee; Byung Joo Park; Jun Suk Kim; on behalf of the Korean Cancer Study Group

Publisher: Springer
Year: 2007
Tongue: English
Weight: 246 KB
Volume: 61
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-007-0444-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fixed-dose-rate gemcitabine combined wit

Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas

✍ David Goldstein; M. Corona Gainford; Chris Brown; Niall Tebbutt; Stephen P. Ackl 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 268 KB

A phase II study of gemcitabine in combi

A phase II study of gemcitabine in combination with oxaliplatin as first-line chemotherapy in patients with inoperable biliary tract cancer

✍ Hyun Jung Kim; Nam Su Lee; Sang-Cheol Lee; Sang Byung Bae; Chan Kyu Kim; Young G 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 347 KB

Phase II study of single-agent gemcitabi

Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancer

✍ Takuji Okusaka; Hiroshi Ishii; Akihiro Funakoshi; Kenji Yamao; Shinichi Ohkawa; 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 214 KB

A phase II randomized trial of gemcitabi

A phase II randomized trial of gemcitabine-docetaxel versus gemcitabine-cisplatin in patients with advanced non-small cell lung carcinoma

✍ Joaquín Casal Rubio; S. Vázquez; F. Vázquez; M. Amenedo; J. L. Fírvida; J. R. Me 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 255 KB

A phase II trial of gemcitabine in patie

A phase II trial of gemcitabine in patients with advanced hepatocellular carcinoma

✍ Charles S. Fuchs; Jeffrey W. Clark; David P. Ryan; Mathew H. Kulke; Haesook Kim; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 2 views

## Abstract ## BACKGROUND There is no effective systemic therapy for patients with hepatocellular carcinoma. A recent trial reported a moderate antitumor activity for gemcitabine among Asian patients with advanced hepatocellular carcinoma. This led to our examination of the efficacy and tolerabili

Multicenter, phase II study of gemcitabi

Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer

✍ Takashi Sasaki; Hiroyuki Isayama; Yousuke Nakai; Yukiko Ito; Hirofumi Kogure; Os 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 169 KB